三种疏水性丙烯酸人工晶状体五年Nd:YAG后囊切开累积发生率及危险因素
全体为13.2%,ZCB00、SN60WF、ZA9003分别为18.1%、11.5%、9.6%;校正其他预测因素后SN60WF与ZA9003较ZCB00分别降低38%和47%的亚风险。
要点
- 5年Nd:YAG后囊切开累积发生率全体为13.2%(95%CI 12.5%-14.0%)。
- ZCB00为18.1%、SN60WF为11.5%、ZA9003为9.6%。
- 较ZCB00,SN60WF与ZA9003的亚风险比分别为0.62与0.53。
核心结论
- 真实世界证据提示SN60WF或ZA9003眼较ZCB00眼的Nd:YAG后囊切开累积发生率显著更低。
研究设计与样本
- 回顾性队列研究,复习芬兰Kymenlaakso中央医院2007至2016年手术登记。
- 采用竞争风险法估算Nd:YAG后囊切开累积发生率,并用竞争风险回归评估危险因素。
主要发现
- 全体5年Nd:YAG后囊切开累积发生率为13.2%(95%CI 12.5%-14.0%)。
- ZCB00、SN60WF、ZA9003的5年累积发生率分别为18.1%(16.5%-20.0%)、11.5%(10.5%-12.6%)、9.6%(8.2%-11.4%)。
- 校正其他预测因素后,SN60WF较ZCB00的亚风险比SHR=0.62(95%CI 0.54-0.71;P<.001),ZA9003较ZCB00的SHR=0.53(95%CI 0.43-0.64;P<.001)。
- 年龄小于60岁、女性、植入屈光度<22.5 D的人工晶状体与Nd:YAG后囊切开风险增加相关。
关键数值与推荐
- 5年Nd:YAG后囊切开累积发生率:全体13.2%(95%CI 12.5%-14.0%)。
- ZCB00为18.1%(16.5%-20.0%)、SN60WF为11.5%(10.5%-12.6%)、ZA9003为9.6%(8.2%-11.4%)。
- SN60WF较ZCB00的SHR=0.62(95%CI 0.54-0.71;P<.001),ZA9003较ZCB00的SHR=0.53(95%CI 0.43-0.64;P<.001)。
- 风险增加相关因素包括年龄<60岁、女性、人工晶状体屈光度<22.5 D。
临床怎么用
- 选择疏水性丙烯酸人工晶状体时可参考不同型号的5年Nd:YAG后囊切开累积发生率差异。
- 对年龄<60岁、女性或植入<22.5 D人工晶状体的患者,可加强术后后囊混浊的随访与告知。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the 5-year cumulative incidence and risk factors of Nd:YAG capsulotomy between hydrophobic acrylic intraocular lenses (IOLs). DESIGN: A retrospective cohort study. METHODS: A review of the registry of operations between the years 2007 and 2016 was carried out at the Ophthalmology Unit of Kymenlaakso Central Hospital, Kotka, Finland. A total of 10 044 eyes having cataract surgery and in-the-bag implantation of ZCB00 (Abbott Medical Optics Johnson & Johnson Vision, Inc, Abbott Park, Illinois, USA), SN60WF (Alcon Laboratories, Inc, Fort Worth, Texas, USA), or ZA9003 (Abbott Medical Optics Johnson & Johnson Vision, Inc) IOLs were included in the study. The cumulative incidence of Nd:YAG capsulotomy was estimated with competing risks methodology. Competing risks regression modeling was used to evaluate potential risk factors, including the patient's age, sex, type of IOL, dioptric power of IOL, and operating surgeon's seniority. RESULTS: The 5-year cumulative incidence of Nd:YAG capsulotomy after cataract surgery was 13.2% (95% confidence interval [CI] 12.5%-14.0%) for all eyes and 18.1% (16.5%-20.0%), 11.5% (10.5%-12.6%), and 9.6% (8.2%-11.4%) for ZCB00, SN60WF, and ZA9003 IOLs, respectively. Implantation of SN60WF and ZA9003 IOLs was associated with a 38% and 47% subhazard reduction (SHR), respectively, compared to ZCB00, after accounting for other predictors (SHR = 0.62; 95% CI 0.54-0.71; P < .001 and SHR = 0.53; 95% CI 0.43-0.64; P < .001). Increased risk of Nd:YAG capsulotomy was associated with eyes of patients aged younger than 60 years, female sex, and eyes implanted with an IOL of <22.5 diopters power. CONCLUSION: Real-world evidence suggests that the cumulative incidence of Nd:YAG capsulotomy is significantly lower in eyes receiving SN60WF or ZA9003 IOLs compared to ZCB00.
引用
- Lindholm JM, Laine I, Tuuminen R, et al. Five-Year Cumulative Incidence and Risk Factors of Nd:YAG Capsulotomy in 10 044 Hydrophobic Acrylic 1-Piece and 3-Piece Intraocular Lenses. Am J Ophthalmol. 2019. PMID: 30689988. doi:10.1016/j.ajo.2019.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。